Ryosuke Munakata, Alexandre Olry, Tomoya Takemura, Kanade Tatsumi, Takuji Ichino, Cloé Villard, Joji Kageyama, Tetsuya Kurata, Masaru Nakayasu, Florence Jacob, Takao Koeduka, Hirobumi Yamamoto, Eiko Moriyoshi, Tetsuya Matsukawa, Jérémy Grosjean, Célia Krieger, Akifumi Sugiyama, Masaharu Mizutani, Frédéric Bourgaud, Alain Hehn, Kazufumi Yazaki
Journal: Proceedings of the National Academy of Sciences of the United States of America 2021;118(17):e2022294118
PMID: 33883279
Plants produce ∼300 aromatic compounds enzymatically linked to prenyl side chains via C-O bonds. These -prenylated aromatic compounds have been found in taxonomically distant plant taxa, with some of them being beneficial or detrimental to human health. Although their -prenyl moieties often play crucial roles in the biological activities of these compounds, no plant gene encoding an aromatic -prenyltransferase (-PT) has been isolated to date. This study describes the isolation of an aromatic -PT gene, , belonging to the UbiA superfamily, from grapefruit ( × Rutaceae). This gene was shown responsible for the biosynthesis of -prenylated coumarin derivatives that alter drug pharmacokinetics in the human body. Another coumarin -PT gene encoding a protein of the same family was identified in , an apiaceous medicinal plant containing pharmaceutically active -prenylated coumarins. Phylogenetic analysis of these -PTs suggested that aromatic -prenylation activity evolved independently from the same ancestral gene in these distant plant taxa. These findings shed light on understanding the evolution of plant secondary (specialized) metabolites via the UbiA superfamily.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.